Cargando…

Chest X-ray survey in the follow-up of breast cancer patients.

The authors report on 182 cases of intrathoracic metastases (ITM = lung, pleura or mediastinum) observed as first single recurrences in the course of the follow-up of patients treated for primary breast cancer. ITM were detected on standard two-views chest X-ray (CXR) at regular follow-up visits and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciatto, S., Pacini, P., Andreoli, C., Cecchini, S., Iossa, A., Grazzini, G., Buranelli, F., Campa, T., Costa, A., Magni, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247331/
https://www.ncbi.nlm.nih.gov/pubmed/2803907
_version_ 1782150959013560320
author Ciatto, S.
Pacini, P.
Andreoli, C.
Cecchini, S.
Iossa, A.
Grazzini, G.
Buranelli, F.
Campa, T.
Costa, A.
Magni, A.
author_facet Ciatto, S.
Pacini, P.
Andreoli, C.
Cecchini, S.
Iossa, A.
Grazzini, G.
Buranelli, F.
Campa, T.
Costa, A.
Magni, A.
author_sort Ciatto, S.
collection PubMed
description The authors report on 182 cases of intrathoracic metastases (ITM = lung, pleura or mediastinum) observed as first single recurrences in the course of the follow-up of patients treated for primary breast cancer. ITM were detected on standard two-views chest X-ray (CXR) at regular follow-up visits and in absence of subjective symptoms (102 A cases) or in the interval between two consecutive planned controls because of the onset of subjective symptoms (80 S cases). The average disease-free interval since primary treatment was significantly shorter in A with respect to S cases (40.3 vs. 28.5 months, P less than 0.001) as a consequence of the early detection achieved by CXR survey. On the contrary, prognosis was not influenced by ITM early diagnosis as the 10-year survival since primary treatment did not differ significantly between A or S cases (12% vs. 10%, P = 0.68). Results were confirmed on multivariate (Cox's) analysis, adjusting for potential confounders such as age or nodal status. Periodic CXR survey looks a very questionable policy as it does not seem to have any favourable impact on prognosis. Its routine use in breast cancer patients should thus be carefully reconsidered.
format Text
id pubmed-2247331
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22473312009-09-10 Chest X-ray survey in the follow-up of breast cancer patients. Ciatto, S. Pacini, P. Andreoli, C. Cecchini, S. Iossa, A. Grazzini, G. Buranelli, F. Campa, T. Costa, A. Magni, A. Br J Cancer Research Article The authors report on 182 cases of intrathoracic metastases (ITM = lung, pleura or mediastinum) observed as first single recurrences in the course of the follow-up of patients treated for primary breast cancer. ITM were detected on standard two-views chest X-ray (CXR) at regular follow-up visits and in absence of subjective symptoms (102 A cases) or in the interval between two consecutive planned controls because of the onset of subjective symptoms (80 S cases). The average disease-free interval since primary treatment was significantly shorter in A with respect to S cases (40.3 vs. 28.5 months, P less than 0.001) as a consequence of the early detection achieved by CXR survey. On the contrary, prognosis was not influenced by ITM early diagnosis as the 10-year survival since primary treatment did not differ significantly between A or S cases (12% vs. 10%, P = 0.68). Results were confirmed on multivariate (Cox's) analysis, adjusting for potential confounders such as age or nodal status. Periodic CXR survey looks a very questionable policy as it does not seem to have any favourable impact on prognosis. Its routine use in breast cancer patients should thus be carefully reconsidered. Nature Publishing Group 1989-07 /pmc/articles/PMC2247331/ /pubmed/2803907 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Ciatto, S.
Pacini, P.
Andreoli, C.
Cecchini, S.
Iossa, A.
Grazzini, G.
Buranelli, F.
Campa, T.
Costa, A.
Magni, A.
Chest X-ray survey in the follow-up of breast cancer patients.
title Chest X-ray survey in the follow-up of breast cancer patients.
title_full Chest X-ray survey in the follow-up of breast cancer patients.
title_fullStr Chest X-ray survey in the follow-up of breast cancer patients.
title_full_unstemmed Chest X-ray survey in the follow-up of breast cancer patients.
title_short Chest X-ray survey in the follow-up of breast cancer patients.
title_sort chest x-ray survey in the follow-up of breast cancer patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247331/
https://www.ncbi.nlm.nih.gov/pubmed/2803907
work_keys_str_mv AT ciattos chestxraysurveyinthefollowupofbreastcancerpatients
AT pacinip chestxraysurveyinthefollowupofbreastcancerpatients
AT andreolic chestxraysurveyinthefollowupofbreastcancerpatients
AT cecchinis chestxraysurveyinthefollowupofbreastcancerpatients
AT iossaa chestxraysurveyinthefollowupofbreastcancerpatients
AT grazzinig chestxraysurveyinthefollowupofbreastcancerpatients
AT buranellif chestxraysurveyinthefollowupofbreastcancerpatients
AT campat chestxraysurveyinthefollowupofbreastcancerpatients
AT costaa chestxraysurveyinthefollowupofbreastcancerpatients
AT magnia chestxraysurveyinthefollowupofbreastcancerpatients